Literature DB >> 16423048

Reasons why DBA/2 mice are resistant to malarial infection: expansion of CD3int B220+ gammadelta T cells with double-negative CD4- CD8- phenotype in the liver.

Hanaa Y Bakir1, Chikako Tomiyama-Miyaji, Hisami Watanabe, Toru Nagura, Toshihiko Kawamura, Hiroho Sekikawa, Toru Abo.   

Abstract

DBA/2 (H-2(d)) mice are known to be more resistant than C57BL/6 (B6, H-2(b)) mice to the non-lethal 17XNL strain of Plasmodium yoelii. This is a very strange phenomenon because the functions of conventional T cells, especially CD8(+) T cells, are known to be somewhat lower in DBA/2 mice than in other strains of mice. We examined herein how immune responses differed between DBA/2 mice and B6 mice during malarial infection. DBA/2 mice and (DBA/2 x B6)F(1) (BDF(1), H-2(b/d)) mice were found to have milder parasitaemia and to recover more quickly from malarial infection than B6 mice. These DBA/2 and BDF(1) mice were also found to experience a marked expansion of interleukin (IL)-2Rbeta(+) CD3(int) cells and gammadelta T cells in the liver, especially in the recovery phase. The expansion of unconventional T cells (i.e. B220(+) T cells) was also marked in DBA/2 and BDF(1) mice. The majority of B220(+) T cells were gammadelta T cells and these T cells were double-negative CD4(-) CD8(-). More importantly, the production of immunoglobulin M (IgM)-type anti-DNA autoantibody was also higher in DBA/2 and BDF(1) mice than in B6 mice. In conjunction with data on cytokine production, these results indicate that primitive T and B cells, namely autoreactive extrathymic T cells and autoantibody-producing B cells, may be much more activated in DBA/2 mice and therefore resistant to the non-lethal 17XNL strain of P. yoelii.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423048      PMCID: PMC1782202          DOI: 10.1111/j.1365-2567.2005.02273.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR V(beta)8 during experimental cerebral malaria.

Authors:  M I Boubou; A Collette; D Voegtlé; D Mazier; P A Cazenave; S Pied
Journal:  Int Immunol       Date:  1999-09       Impact factor: 4.823

2.  Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.

Authors:  M K Mannoor; A Weerasinghe; R C Halder; S Reza; M Morshed; A Ariyasinghe; H Watanabe; H Sekikawa; T Abo
Journal:  Cell Immunol       Date:  2001-08-01       Impact factor: 4.868

3.  Simultaneous activation of natural killer T cells and autoantibody production in mice injected with denatured syngeneic liver tissue.

Authors:  T Naito; T Kawamura; M Bannai; T Kosaka; H Kameyama; K Shimamura; O Hoshi; T Ushiki; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

4.  Association of intermediate T cell receptor cells, mainly their NK1.1(-) subset, with protection from malaria.

Authors:  A Weerasinghe; H Sekikawa; H Watanabe; K Mannoor; S R Morshed; R C Halder; T Kawamura; T Kosaka; C Miyaji; H Kawamura; S Seki; T Abo
Journal:  Cell Immunol       Date:  2001-01-10       Impact factor: 4.868

5.  Cerebral malaria in mice: interleukin-2 treatment induces accumulation of gammadelta T cells in the brain and alters resistant mice to susceptible-like phenotype.

Authors:  A Haque; H Echchannaoui; R Seguin; J Schwartzman; L H Kasper; S Haque
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 6.  Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans.

Authors:  J Lou; R Lucas; G E Grau
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.

Authors:  Ryoko Miyakawa; Chikako Miyaji; Hisami Watanabe; Hisashi Yokoyama; Chika Tsukada; Hitoshi Asakura; Toru Abo
Journal:  Eur J Immunol       Date:  2002-09       Impact factor: 5.532

8.  Essential role of extrathymic T cells in protection against malaria.

Authors:  M Kaiissar Mannoor; Ramesh C Halder; Sufi Reza M Morshed; Anoja Ariyasinghe; Hanaa Y Bakir; Hiroki Kawamura; Hisami Watanabe; Hiroho Sekikawa; Toru Abo
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

9.  Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain.

Authors:  Sébastien Bagot; Susana Campino; Carlos Penha-Gonçalves; Sylviane Pied; Pierre-André Cazenave; Dan Holmberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

10.  Deletion of T cells bearing the V beta8.1 T-cell receptor following mouse mammary tumor virus 7 integration confers resistance to murine cerebral malaria.

Authors:  Olivier Gorgette; Alexandre Existe; Mariama Idrissa Boubou; Sébastien Bagot; Jean-Louis Guénet; Dominique Mazier; Pierre-André Cazenave; Sylviane Pied
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  9 in total

1.  Enhancement of dendritic cell activation via CD40 ligand-expressing γδ T cells is responsible for protective immunity to Plasmodium parasites.

Authors:  Shin-Ichi Inoue; Mamoru Niikura; Satoru Takeo; Shoichiro Mineo; Yasushi Kawakami; Akihiko Uchida; Shigeru Kamiya; Fumie Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

2.  Malaria protection in beta 2-microglobulin-deficient mice lacking major histocompatibility complex class I antigens: essential role of innate immunity, including gammadelta T cells.

Authors:  Tomoyo Taniguchi; Saoko Tachikawa; Yasuhiro Kanda; Toshihiko Kawamura; Chikako Tomiyama-Miyaji; Changchun Li; Hisami Watanabe; Hiroho Sekikawa; Toru Abo
Journal:  Immunology       Date:  2007-10-03       Impact factor: 7.397

3.  Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells.

Authors:  Karmel A Allison; Eniko Sajti; Jana G Collier; David Gosselin; Ty Dale Troutman; Erica L Stone; Stephen M Hedrick; Christopher K Glass
Journal:  Elife       Date:  2016-07-04       Impact factor: 8.140

Review 4.  Roles of IFN-γ and γδ T Cells in Protective Immunity Against Blood-Stage Malaria.

Authors:  Shin-Ichi Inoue; Mamoru Niikura; Shoichiro Mineo; Fumie Kobayashi
Journal:  Front Immunol       Date:  2013-08-29       Impact factor: 7.561

Review 5.  Gamma/Delta T Cells and Their Role in Protection Against Malaria.

Authors:  Katrien Deroost; Jean Langhorne
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

6.  Metformin Promotes the Protection of Mice Infected With Plasmodium yoelii Independently of γδ T Cell Expansion.

Authors:  Mana Miyakoda; Ganchimeg Bayarsaikhan; Daisuke Kimura; Masoud Akbari; Heiichiro Udono; Katsuyuki Yui
Journal:  Front Immunol       Date:  2018-12-13       Impact factor: 7.561

Review 7.  Accelerator or Brake: Immune Regulators in Malaria.

Authors:  Chunmei Cai; Zhiqiang Hu; Xiao Yu
Journal:  Front Cell Infect Microbiol       Date:  2020-12-10       Impact factor: 5.293

8.  Resistance and Susceptibility to Malarial Infection: A Host Defense Strategy against Malaria.

Authors:  Hanaa Bakir; Doaa Yones; Lamia Galal; Enas Huseein
Journal:  Iran J Parasitol       Date:  2015 Oct-Dec       Impact factor: 1.012

9.  A Unique Subset of γδ T Cells Expands and Produces IL-10 in Patients with Naturally Acquired Immunity against Falciparum Malaria.

Authors:  Tomoyo Taniguchi; Kaiissar Md Mannoor; Daisuke Nonaka; Hiromu Toma; Changchun Li; Miwako Narita; Viengxay Vanisaveth; Shigeyuki Kano; Masuhiro Takahashi; Hisami Watanabe
Journal:  Front Microbiol       Date:  2017-07-19       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.